Microbot Medical (MBOT) - EV/EBITDA Multiple

Microbot Medical, Inc - graphic logo of issuer MBOT

The EV/EBITDA price trend reflected below is 0.00. Microbot Medical Inc. (MBOT) is expanding the application of its robots to cover neurosurgery and cardiology, while mitigating regulatory risks through expansion into foreign markets. Innovative vascular microrobots provide the company with exceptional market power and the ability to maintain flexible pricing power. Currently, management's success depends on clinical test results and the acquisition of strategic partners.

MBOT Microbot Medical Inc: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/10/2026

Analytical breakdowns for microbotmedical.com (MBOT)

- stock price and consensus target price:
Stock Quotes Microbot Medical Inc|MBOT - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Microbot Medical, Inc|MBOT - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Microbot Medical|MBOT - Accounting Capitalization|Market Value to Book Value Ratio microbotmedical.com|MBOT - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio Microbot Medical Inc.|MBOT - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Microbot Medical|MBOT - Aggregate Debt Obligations|Debt to Book Value Microbot Medical, Inc|MBOT - Company Long-Term Debts|Company Short-Term Debt Microbot Medical|Quick Ratio microbotmedical.com
- business earnings and investment ratios data:
MBOT - Company Net Income|Expected Profit Microbot Medical Inc.|MBOT - Price to Earnings Multiple|Projected Price to Earnings Microbot Medical Inc.|MBOT - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Microbot Medical, Inc|MBOT - Operating income before deduction of amortization|Earnings per share for the last twelve months Microbot Medical|MBOT - Net earnings per share for the last 12 months|Quarterly EPS earnings growth microbotmedical.com|MBOT - Expected net earnings per share growth this year|Earnings growth forecast for next year Microbot Medical Inc.
Summary company analysis:Microbot Medical Inc (MBOT)
Manufactured products of Microbot Medical

This ratio is calculated as the total enterprise value, including net debt, divided by earnings before depreciation and amortization. The metric determines the payback period of assets, where extreme values signal either overvaluation or financial insolvency. For Microbot Medical Inc. (MBOT) and its innovative Liberty system, this calculation is critical when assessing the capital intensity of robotic surgery development. By analyzing the current EV/EBITDA trend of Microbot Medical Inc. (MBOT), an investor can evaluate the market value of these technologies.

Competitors of Microbot Medical Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|Utah Medical (UTMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio KORU Medical|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|pro-dex.com (PDEX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ZTEK|Enterprise Value to EBITDA Ratio Elutia Inc ELUT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Milestone Scientific Corp MLSS|Business Value to Operating Income Before Depreciation NXGL|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Harvard Bioscience Inc.|FEMY: EV/EBITDA Multiple|MHUA (Meihua Medical Technologies Co., Ltd.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|Company Value to EBITDA Callan JMB Corp CJMB|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|Enterprise Value to Operating Income Before Depreciation Ratio NURO